Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00780338 · ClinicalTrials.gov registry record · Phase 2
Enhancing Prevention Capacity With Developmental Assets and Getting to Outcomes
A Phase 2 study of Substance Abuse, sponsored by RAND.
- Completed
- Registry status
- Phase 2
- Development phase
- 376
- Enrollment target
- 1
- Study location
NCT00780338 is a Phase 2 study of Substance Abuse that has completed, run by RAND. The registered enrollment target is 376 participants, below the 5,253-participant average among 58 other Substance Abuse trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00780338, a Phase 2 study of Substance Abuse, has completed, sponsored by RAND.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 376 participants
- Enrollment target
- 1
- Study location
Study Summary
Alcohol and other drug use among youth is costly for communities. More research is needed about how to best support community based prevention programs and how community prevention expertise can inform the research process. The National Institute on Drug Abuse has funded a 5 year collaboration of the RAND Corporation, Search Institute and its training division, Vision Training Associates, Communities for Children and Youth, and the University of Southern Maine to implement and assess the impact on prevention coalitions, the combination of two complimentary, community-based interventions: Developmental Assets, which supports community mobilization and collaboration to promote positive youth development, and Getting To Outcomes (GTO), which enhances community capacity to complete critical prevention tasks (e.g., evaluation). The purpose of the project is to investigate: 1) How well is the Assets-GTO intervention delivered, how much is it used, and what coalitions think about it; 2) The extent to which the Assets-GTO approach enhances the prevention capacity (knowledge, attitudes, and skills) of individual coalition members and the quality of prevention performance; and 3) Whether enhanced prevention capacity improves alcohol and drug outcomes among youth. Twelve community-based prevention coalitions in Maine (part of Communities for Children and Youth) will participate. Six coalitions-determined at random-will receive manuals, training, and on-site technical assistance consisting of bi-Weekly meetings between A-GTO 4 ME! and key coalition staff. The other six coalitions will continue practice as usual, but will receive an abbreviated version of the Assets-GTO intervention near the end of the project. A Community Research Workgroup made of coalition representatives will review all aspects of the study and interim findings and facilitate dissemination on A-GTO 4 ME! The project will demonstrate and evaluate strategies to strengthen the prevention capacity of community o
Conditions Studied
Interventions
- OTHER Assets Getting To Outcomes
Study Locations (1)
Pennsylvania
- RAND Corporation - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 376 participants |
| Start Date | 2008-06 |
| Est. Completion | 2014-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00780338
The ClinicalTrials.gov registry entry for NCT00780338 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 376 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,253-participant average among 58 other Substance Abuse trials with a reported enrollment target (93% lower). The listed sponsor is RAND, which has 78 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Substance Abuse appearing as the primary indexed condition, and to 1 intervention - of which Assets Getting To Outcomes is the first listed.
NCT00780338 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00780338 about?
NCT00780338 is a clinical study titled "Enhancing Prevention Capacity With Developmental Assets and Getting to Outcomes". Alcohol and other drug use among youth is costly for communities. More research is needed about how to best support community based prevention programs and how community prevention expertise can inform the research process. The National Institute on Drug Abuse has funded a 5 year collaboration of th...
What is the current status of trial NCT00780338?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 376 participants. The study started on 2008-06. Estimated completion is 2014-03.
What conditions does trial NCT00780338 study?
This clinical trial studies the following conditions: Substance Abuse.
What interventions are being tested in trial NCT00780338?
The interventions under investigation include: Assets Getting To Outcomes (OTHER).
Who is sponsoring clinical trial NCT00780338?
This trial is sponsored by RAND, which has 78 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00780338 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Abuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Treatments for Homeless Youths
COMPLETED · Phase 2
-
Substance Treatment and HIV Testing and Referral System
COMPLETED · Phase 2
-
Study of Medical Treatment for Methamphetamine Addiction
COMPLETED · Phase 2
-
Evaluation of Atomoxetine for Cocaine Dependence: A Pilot Trial
COMPLETED · Phase 2
-
Aripiprazole Treatment for Methamphetamine Dependence Among High-risk Individuals
COMPLETED · Phase 2
-
Building Outcomes With Observation-Based Supervision: An FFT Effectiveness Trial
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.